FDA Inspection 1100141 — Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc.
The FDA completed an inspection of Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc. on June 27, 2019 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
Clinical BA/BE